BXB – 1H21 Earnings
Brambles 1H21 underlying profit was ahead of consensus.
FY21 guidance was upgraded with revenue growth now expected
between 4-6% and underlying profit growth +5 to 7%.
We have BXB on a forward yield of 3.2%

Brambles 1H21 underlying profit was ahead of consensus.
FY21 guidance was upgraded with revenue growth now expected
between 4-6% and underlying profit growth +5 to 7%.
We have BXB on a forward yield of 3.2%

Sonic Healthcare is looking oversold and we believe buying support will build within the $32.50 – $33.50 price range.

Xero is under Algo Engine buy conditions and is a current holding in our ASX 100 model.

Sorry, but this content is restricted to our members.
Please login with your account or register for a free trial. If your trial has expired, then you may renew it here.
If you are having an issue with your account, then please get in touch with us.
ResMed is under Algo Engine buy conditions and we see buying support building.

NCM is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
We see price support developing near the $25 – $26 level.

Goodman is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
FY20 NPAT was up 12.5% to A$1,060.2mn, and the company is guiding to 9% EPS growth in FY21.
Relative to its A-REIT peers, GMG is trading on an elevated earnings multiple, however, this is not the case when compared to its global peers.

Downer EDI is now under Algo Engine buy conditions, following the entry signal at $5.15. The stock is now included in our ASX 100 model portfolio.
The company is making progress on its urban growth strategy and the divestments within the mining services sector are helping to sure up the balance sheet and de-risk the business outlook.
We see scope for double digit EPS growth into FY22 & FY23.

,
CSL is under Algo Engine buy conditions and is a current holding in our ASX 100 model portfolio.
Buy between the $240 – $270 price range.

APA is under Algo Engine buy conditions and we see buying support building, as the price action crosses back above 10-day average.
